ClinicalTrials.Veeva

Menu
S

SurGal Clinic | Gastroenterology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Risankizumab
Mirikizumab
Lutikizumab

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 6 total trials

A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis (COMMAND)

The purpose of this study is to evaluate safety and efficacy of risankizumab in participants with ulcerative colitis (UC) in participants who respond...

Active, not recruiting
Ulcerative Colitis (UC)
Drug: placebo for risankizumab
Drug: risankizumab

The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with...

Enrolling
Obesity or Overweight
Ulcerative Colitis
Drug: Mirikizumab
Drug: Placebo

The main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizumab and concomitantly administ...

Enrolling
Obesity or Overweight
Crohn's Disease
Drug: Placebo
Drug: Tirzepatide

Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting...

Enrolling
Crohn's Disease
Drug: Risankizumab
Drug: Trosunilimab

Trial sponsors

AbbVie logo
Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems